Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Singapore's efforts to achieve measles elimination in 2018.
See W, Ng YK, Cui L, Kita Y, Ooi SP, Lee V, Heng DMK, Lin RTP. See W, et al. Western Pac Surveill Response J. 2021 Jul 12;12(3):5-16. doi: 10.5365/wpsar.2019.10.4.002. eCollection 2021 Jul-Sep. Western Pac Surveill Response J. 2021. PMID: 34703631 Free PMC article.
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.
Jammihal T, Saliby RM, Labaki C, Soulati H, Gallegos J, Peris A, McCurry D, Yu C, Shah V, Poduval D, El Zarif T, El Ahmar N, Laimon YN, Eid M, Sheshdeh AB, Krajewski KM, Büttner FA, Schwab M, Heng D, Casellas RC, Rai K, Zacharias Millward NM, Msaouel P, Karam J, Signoretti S, Van Allen E, Choueiri TK, Braun DA, Shukla SA. Jammihal T, et al. Among authors: heng d. Nat Cancer. 2025 Jan 9. doi: 10.1038/s43018-024-00896-w. Online ahead of print. Nat Cancer. 2025. PMID: 39789182
Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis.
Gupta M, Wells C, Regan MM, Xie W, Navani V, Saliby RM, Basappa NS, Donskov F, Yuasa T, Takemura K, Kollmannsberger CK, Crumbaker M, Lalani AA, Powles T, Ebrahimi H, McKay RR, Lee JL, Kanesvaran R, Choueiri TK, Heng DYC. Gupta M, et al. Among authors: heng dyc. Eur Urol Oncol. 2024 Dec 31:S2588-9311(24)00293-1. doi: 10.1016/j.euo.2024.12.011. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39743422
Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate Cancer.
Gagnon R, Kish EK, Cook S, Takemura K, Cheng BYC, Bressler K, Heng DYC, Alimohamed N, Ruether D, Lee-Ying RM, Bose P, Kolinsky MP, Vasquez C, Samuel D, Lewis J, Faridi R, Borkar M, Fairey A, Bismar T, Yip S. Gagnon R, et al. Among authors: heng dyc. Clin Genitourin Cancer. 2024 Nov 23;23(1):102274. doi: 10.1016/j.clgc.2024.102274. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39689666 Free article.
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma.
Panian J, Zhong C, Choi SH, Ly K, Quinn R, Ferrier E, Saad E, Saliby RM, Malvar C, Pal S, Ebrahimi H, Tran B, Jude E, Lalani AK, Suarez C, Velasco G, Kanesvaran R, Zarba M, Liow E, El Hajj Chehade R, Choueiri TK, Heng DYC, McKay RR. Panian J, et al. Among authors: heng dyc. Eur Urol Focus. 2024 Dec 7:S2405-4569(24)00257-8. doi: 10.1016/j.euf.2024.11.011. Online ahead of print. Eur Urol Focus. 2024. PMID: 39648092
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?
Soytas M, Dragomir A, Sawaya GB, Hesswani C, Tanguay M, Finelli A, Wood L, Rendon R, Bansal R, Lalani AK, Heng DYC, Bhindi B, Basappa NS, Dean L, So A, Nayak JG, Bjarnason G, Breau R, Lavallee L, Lattouf JB, Pouliot F, Bonert M, Tanguay S. Soytas M, et al. Among authors: heng dyc. BJU Int. 2024 Dec 4. doi: 10.1111/bju.16609. Online ahead of print. BJU Int. 2024. PMID: 39631366
493 results